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Abstract
Gene expression profiling using microarrays has been limited to comparisons of gene expression between small numbers of
samples within individual experiments. However, the unknown and variable sensitivities of each probeset have rendered
the absolute expression of any given gene nearly impossible to estimate. We have overcome this limitation by using a very
large number (.10,000) of varied microarray data as a common reference, so that statistical attributes of each probeset,
such as the dynamic range and threshold between low and high expression, can be reliably discovered through meta-
analysis. This strategy is implemented in a web-based platform named ‘‘Gene Expression Commons’’ (https://gexc.stanford.
edu/) which contains data of 39 distinct highly purified mouse hematopoietic stem/progenitor/differentiated cell
populations covering almost the entire hematopoietic system. Since the Gene Expression Commons is designed as an open
platform, investigators can explore the expression level of any gene, search by expression patterns of interest, submit their
own microarray data, and design their own working models representing biological relationship among samples.
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Introduction
Gene expression microarray technology has allowed a global
measurements of gene expression status in diverse cells and
tissues across species [1]. Technological advances enable
integration of thousands of probesets on a single chip, providing
mRNA levels to be measured for almost all known protein-
coding gene in the genome. However, since each probeset
intrinsically has a different efficiency of hybridization due to
differences in target sequences, current methodologies of array-
based global gene expression analysis are limited to profiling
relative differences in gene expression among samples rather than
absolute gene expression analyses of a particular sample [1]
(Figure 1A left). The output of differentially regulated genes is
unique to the combination of samples compared, and the
relative differences are frequently misinterpreted because there is
no assurance that every probeset has the same dynamic range
of gene expression values. For instance, the biological interpre-
tation of 2-fold changes (1 log2 shift) for a probeset that has
small dynamic range compared to a probeset that has large
dynamic range will be different. Moreover, genes whose
expression level does not vary significantly between samples
within a given study are frequently ignored regardless of their
expression intensity. These limitations have created a bottleneck
for generalizing results of gene expression microarray assays
across experiments and across laboratories.
To overcome these limitations, we hypothesized that a very
large number of publicly available microarray data from a
particular microarray platform could be used as a common
reference that might be enable empirical estimation of the absolute
expression level of a given gene. If the common reference is large
enough, meta-analysis could be applied to the common reference
to compute the distribution of data, dynamic-range, and a
threshold to distinguish high expression from low expression for
each probeset. Using such an approach, we now demonstrate that
absolute gene expression profiling can be achieved by mapping
sample data against a common reference obtained by meta-
analysis (Figure 1A right).
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Results
Common Reference and Probeset Meta-Profile Database
In our initial experiment, we determined the size of the
common reference required to perform meta-analysis with
sufficient statistical power. We focused on Affymetrix microarrays
because of the abundance of publicly available data. We
downloaded 11,939 Affymetrix Mouse Genome 430 2.0 and
25,299 Affymetrix Human Genome U133 Plus 2.0 gene expres-
sion microarray data from the NCBI Gene Expression Omnibus
(GEO) public repository [2]. From the pool of microarray data
downloaded, we randomly selected 10, 20, 40, 80, 160, 320, 640,
1280, 2560, and 5120 data as a hypothetical common reference.
Each common reference sample was normalized using the RMA
algorithm [3], and for each probeset, the dynamic range was
calculated as the difference between the lowest and the highest
expression values among the data. Next, one additional micro-
array data was randomly chosen from the pool as the ‘‘actual
sample’’ and was normalized with each hypothetical common
reference. To test if adding the ‘‘actual sample’’ changed the
computed dynamic ranges of probesets significantly, we analyzed
the number of probesets for which the expression intensity of the
‘‘actual sample’’ falls outside the dynamic range calculated from
the hypothetical common reference. This number decreased
exponentially as the size of hypothetical common reference
increased (Figure 1B). As shown in Figure 1B, the dynamic range
becomes stable as the size of the hypothetical common reference
approaches 2560, and the probabilities of false estimation of the
probeset dynamic range are less than 0.1% for mouse, and 0.5%
for human, respectively. We repeated this experiment five times
and observed consistent trends (Table 1 and 2). This result
indicates that if large numbers of microarray data are pooled and
Figure 1. Absolute gene expression profiling with a large-scale common reference and a probeset meta profile database. (A) Relative
vs. absolute gene expression profiling. Conventional methods compare differences in gene expression between samples within an individual
experiment, and result in relative values only (left). In Gene Expression Commons, raw microarray data is individually normalized against a large-scale
common reference, then mapped onto the probeset meta profile. This strategy enables profiling of absolute expression levels of all genes on the
microarray (right). (B) Relationship between the size of the common reference and the accuracy of the probeset dynamic range estimation. The result
of one out of five experiments is shown. The Y-axis represents % probesets with false estimation of dynamic range in mean 6 S.E.M (n = 10). (C) The
dynamic range versus the mean of each probeset in Affymetrix Mouse 430 2.0 (n = 11,939) (left) and Affymetrix Human U133 Plus 2 (n = 25,229) (right)
presented by a density plot and histograms. (D) Graphical representation of probeset meta profile. The Y-axis represents expression intensity without
units in log2 scale. The distribution of expression levels is displayed by a histogram (right side of the axis). The high/low threshold computed is shown
by a solid bar, and the distribution of percentiles in either the high or low expression range is indicated by a gradation of color, displayed as highest
(+100%) in dark red, threshold (0%) in white, lowest (2100%) in dark blue (left side of the axis). Four diverse distributions of probesets for four
different genes (Aak1, Rbx1, Hif1a and Ikzf1) (left), and diverse distribution of four probesets of one gene (Il16) (right) are shown.
doi:10.1371/journal.pone.0040321.g001
Table 1. Size of universal reference and probeset dynamic-range estimation Affymetrix Mouse 430 2.0 (45101 probesets).
False positive on probeset dynamic-range estimation (mean±s.e.m.) [%]
Size of common reference (number of microarrray data)
Exp 10 20 40 80 160 320 640 1280 2560 5120
#1 (n = 10) 16.3861.72 12.9961.69 4.2860.98 1.8860.48 1.1960.48 0.6360.27 0.2560.11 0.1160.04 0.0760.03 0.0460.02
#2 (n = 10) 15.1061.83 10.6762.30 3.9560.91 2.2660.72 1.0060.35 0.5960.25 0.2760.09 0.1460.07 0.0660.02 0.0360.01
#3 (n = 10) 17.6862.16 7.5061.16 4.5161.02 2.5260.55 1.1860.44 0.5460.19 0.2160.06 0.1260.05 0.0560.02 0.0460.02
#4 (n = 10) 18.3762.85 10.8861.49 5.2561.11 2.5960.85 1.0560.30 0.4860.15 0.3260.15 0.1360.06 0.0760.03 0.0360.01
#5 (n = 10) 19.1562.26 7.8661.09 4.6361.10 2.1960.54 1.2760.56 0.5360.17 0.2560.09 0.1360.06 0.0560.02 0.0360.01
Ave 17.3460.72 9.9861.02 4.5260.22 2.2960.13 1.1460.05 0.5560.03 0.2660.02 0.1360.00 0.0660.00 0.0360.00
doi:10.1371/journal.pone.0040321.t001
Table 2. Size of universal reference and probeset dynamic-range estimation Affymetrix Human U133 Plus 2 (54677 probesets).
False positive on probeset dynamic-range estimation (mean±s.e.m.) [%]
Size of common reference (number of microarrray data)
Exp 10 20 40 80 160 320 640 1280 2560 5120
#1 (n = 10) 20.0163.58 12.0163.23 8.7863.42 4.3262.18 3.1461.97 1.6961.18 1.0360.78 0.7160.57 0.3460.28 0.2360.20
#2 (n = 10) 24.1863.89 13.8563.85 8.2863.20 4.7362.35 2.6361.52 1.4460.98 0.9960.71 0.7260.61 0.4660.40 0.3060.28
#3 (n = 10) 22.2864.00 10.0062.49 6.9162.44 3.5661.86 2.6761.49 1.5661.10 0.9860.73 0.6060.47 0.4260.36 0.3260.29
#4 (n = 10) 20.8963.77 12.3263.04 8.7063.24 5.3162.66 2.9861.90 1.9261.36 1.2360.96 0.6660.53 0.5360.47 0.2060.18
#5 (n = 10) 19.1163.77 12.9663.68 5.7862.22 5.7562.98 3.2461.98 1.7361.20 1.1360.87 0.5360.43 0.5860.52 0.2760.24
Ave 21.3060.89 12.2360.64 7.6960.58 4.7360.38 2.9360.12 1.6760.08 1.0760.05 0.6560.04 0.4660.04 0.2760.02
doi:10.1371/journal.pone.0040321.t002
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normalized together, we can estimate the dynamic range of each
probeset with a high degree of confidence, and can use those
pooled data as a ‘‘Common Reference’’. To maximize confidence,
we used all 11,939 Affymetrix mouse 430 2.0 microarray data and
25,229 Affymetrix human U133 Plus 2.0 microarray data for the
first version of the common reference.
Since the common reference contains a large number of data
points for each probeset, various attributes besides the dynamic-
range can be calculated with statistical reliability. Figure 1C
displays the scatter plot of the dynamic range versus the mean of
each probeset obtained from Affymetrix mouse 430 2.0 micro-
arrays (n = 11,939) and Affymetrix human U133 Plus 2.0
microarrays (n = 25,229). The dynamic range varies widely from
1 to 10 in log2 scale in both platforms. This variation clearly
indicates the limitations of conventional selection criteria based on
just the relative fold-change between samples within a single
experiment. The biological context of a 2-fold increase in a
probeset that has a small dynamic range is likely to be more
significant than a 2-fold increase in a probeset in which the highest
level of expression is much more than a 2-fold change. Conversely,
one cannot expect to find a 10-fold change in expression of a gene
with a small dynamic range.
Another important finding is that there is wide variation in the
mean values of probesets with the same dynamic range. Two
different possibilities may explain this phenomenon. First, non-
specific hybridization signals are significantly different for different
probesets. Second, there are a large number of ‘‘housekeeping’’
genes that are highly expressed irrespective of cell type. On the
microarray, both of these two types of probesets are likely present,
but our approach does not distinguish between them.
Because of the large sample size in our common reference, the
distribution of gene expression values for each probeset is
extremely stable. Therefore, the inclusion of additional data in
the future will likely not affect this distribution, as shown in
Figure 1B. Further, we can infer that for each probeset large
numbers of representative low and high gene expression values are
available. Thus, a threshold value which distinguishes high
expression from low expression can be estimated (high/low
threshold). To achieve this, we used the StepMiner algorithm
originally developed to fit step functions [4]. For each probeset, the
expression intensities were sorted from low to high, and a step
function fitted to the sorted expression intensities that minimizes
the square error between the original and the fitted values. This
enabled us to identify a threshold for high versus low expression.
Each individual expression value from the common reference for a
given probeset was assigned a percentile rank. For each probeset,
the meta database provides the high/low threshold, minimum,
maximum.
A graphical presentation of the meta profiles for eight
representative probesets appears in Figure 1D. The Y-axis
represents expression intensity. On the right side of the axis, the
distribution of expression intensities of the data used to generate
the common reference is displayed in a histogram. On the left side
of the axis, the high/low threshold is shown by a solid bar, and the
distribution of percentiles in either the high or low expression
range is displayed by a gradation of color. The probeset for Aak1
(1452632_at) and the probeset for Rbx1 (1416577_a_at) have
almost equivalent dynamic ranges, but their distributions of
expression intensities are strikingly different. The probeset for
Hif1a (1416035_at) has a uni-modal distribution, whereas the
probeset for Ikzf1 (1436312_at) has a bimodal distribution. The
Affymetrix Mouse 430 2.0 microarray contains 4 probesets for
Il16, and each probeset has a distinct dynamic-range and shape of
distribution (Figure 1D, right).
Gene Expression Commons
We developed a computer program to normalize microarray
data of interest against the common reference. As a result of this
processing, the expression intensities and expression percentiles
are obtained for all probesets, and the stability of the results is
greater than 99.9%. Thus, absolute gene expression profiling can be
achieved. We integrated these strategies into an intuitive web inter-
face named ‘‘Gene Expression Commons’’ (https://gexc.stanford.edu).
Figure 2A shows each functional layer of Gene Expression
Commons. Users can search for absolute gene expression with
probeset meta profile information using a web interface.
‘‘Model’’ is a searchable category that represents biological
context and relationships among ‘‘Populations’’ displayed in 2-
dimensions (e.g. Mouse Hematopoiesis Model, described later).
‘‘Population’’ is the most essential unit of data in Gene Expression
Commons, which contains several microarray data that are
biological replicates. Microarray data are normalized individually
with the common reference. Then, the normalized values are
averaged. These averaged values are then mapped onto the
probeset meta-profile in order to obtain the population’s percentile
of expression for each probeset.
The system is designed to enable updating of the common
reference to improve the breadth of available samples. When the
size of publically-available data of Affymetrix mouse 430 2.0
microarray or Affymetrix human U133 Plus 2.0 microarray has
increased significantly, e.g. doubled from current size, we will
introduce a new version of the common reference. Also, other
microarray platforms will be added to the system when the
numbers of publicly available data reaches a point at which
generation of a stable common reference is possible.
Mouse and Human Hematopoiesis Models
Hematopoietic stem cells generate more than 10 distinct
functional cell types every second through multiple intermediate
progenitor stages. Hematopoietic stem cells and many of their
downstream progeny can be readily isolated and molecularly
characterized. To establish a gene expression map of hematopoi-
esis, we highly purified 39 defined hematopoietic populations for
which we have established putative differentiation pathways
(Table 3) from bone marrow, spleen, and thymus utilizing 12-
color digital FACS, and generated gene expression data for each
on the Affymetrix Mouse Genome 430 2.0 microarray platform
(GSE34723) [5,6]. The data of each population were incorporated
into Gene Expression Commons, and a ‘‘Mouse Hematopoiesis’’
Figure 2. Structure and Workflow of Gene Expression Commons. (A) Functional layers of Gene Expression Commons system. Users can select
a Model of interest, and search for absolute gene expression through an intuitive web interface. A Model is a searchable category representing a
biological context and displaying relationships among Populations. A Population contains several microarray data, which are biological replicates.
Users can submit their own Populations, and design Models with a privacy control feature. (B) Seamless search flow at Gene Expression Commons.
Gene Name Search provides absolute gene expression of a particular gene (path a). Expression Pattern Search provides a list of genes with expression
patterns matching the expression pattern of interest designed by user (path b). From the list of genes, absolute expression of a particular gene is
displayed with one click. From the absolute gene expression of a particular gene, the user can obtain a list of genes with the same expression pattern
(path d).
doi:10.1371/journal.pone.0040321.g002
Absolute Gene Expression Profiling Platform
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model was generated (Figure 2B). On the Mouse Hematopoiesis
model, users can search and observe the absolute gene expression
profile of any gene on Affymetrix Mouse Genome 430 2.0
microarray platform simply by searching for the NCBI gene
symbol, gene name, keyword, or probeset ID. For instance, the
gene expression profile of CD19 is shown in Figure 2B (path a).
On the results page, the right column displays the probeset meta
profile including its dynamic range, threshold level, histogram of
data distribution, and calculated low/high expression level
represented by a color-coded heatmap. The left column depicts
the expression level of the gene searched in a heatmap. Red
represents high expression, white represents threshold level
expression, and blue represents low expression. Because of the
size of the common reference data, the expression levels for each
population are stable. Thus, adding another populations to the
‘‘Mouse Hematopoiesis’’ model in the future will not alter the
expression levels of existing populations. This feature is very
important, as discovery of new cell populations will undoubtedly
occur.
If a microarray platform has multiple probesets for a particular
gene, the Gene Expression Commons sorts the results based on the
dynamic range of each probeset. To eliminate potential outliers,
the highest 0.5% and lowest 0.5% of data points are ignored in this
dynamic-range calculation. Probesets are sorted from greatest to
least dynamic range, since the probeset with the largest dynamic
range is likely to be the most informative. However, a probeset
that has wide and single-modal distribution could be probeset with
greater noise.
For each probeset, the Gene Expression Commons displays not
only the dynamic range, but also the threshold value, which
distinguishes high from low expression. This enables searches
based upon particular expression patterns. For instance, genes
expressed only in the B-cell development pathway can be searched
by a few clicks (Figure 2B, path b). A list of genes with an
expression pattern matching the inquiry is displayed, and the user
can then investigate the detailed gene expression profile with one
more click (Figure 2B, path c).
Using this powerful feature, Expression Pattern Search, we can
profile the kinetics of gene expression within the model. For
instance, genes expressed at a high level in all of the populations in
the Mouse Hematopoiesis model can be searched by one click. In
the Mouse Hematopoiesis model, 1722 probesets are always high,
and 11,569 probesets are consistently low. Other genes dynam-
ically change expression among the populations (Figure 3A, left).
This type of profiling cannot be achieved by conventional relative
comparisons of small numbers of samples.
Furthermore, genes highly expressed in a specific population
can be identified (Figure 3A, right). Interestingly, very few genes
specific for a particular hematopoietic population (either high or
low) are detected in the Mouse Hematopoiesis model. This result
suggests that gene expression programs change gradually through-
out hematopoietic differentiation. Lists of genes and further details
can be obtained at Gene Expression Commons (https://gexc.
stanford.edu/).
Gene expression microarray data of publicly available human
hematopoietic populations [7,8] are also available in the Gene
Expression Commons. This Human Hematopoiesis model con-
tains HSC, MPP, and RA-positive progenitor population from
cord blood; HSC, MPP, RA-positive progenitor population, CMP,
MEP, and GMP from healthy adult bone marrow; and LSC, LPC,
and Blast populations from AML patients.
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Figure 3. Gene expression pattern profiling of mouse and human hematopoiesis. Number of genes expressed at very low levels (dark
blue), low levels (light blue), high levels (light red) and very high levels (dark red) in either the Mouse Hematopoiesis Model (A, left) or Human
Hematooiesis Model (B, left). Number of genes expressed at high (red) and low (blue) levels in a specific population in Mouse Hematopoiesis Model
Absolute Gene Expression Profiling Platform
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Gene Expression Commons as an Open Platform
Gene Expression Commons is not only a search engine for
existing gene expression data, but also a universal open platform to
profile absolute gene expression of any microarray data. Users can
submit gene expression microarray data files of their own, or
published microarray data downloaded from public repositories
e.g. GEO. Users can also design their own models by combining
‘‘Populations’’ to represent biological context of interest. Users can
control the privacy level of submitted data and models, and share
private models using group function provided by web platform.
Through this workflow, users can find key genes and expression
patterns by absolute gene expression profiling to identify
candidates relevant to their biological question of interest. Once
a project is published, the population and model used will be
publicly available at the Gene Expression Commons.
Discussion
We described a strategy for absolute gene expression profiling
based on meta-analysis of large-scale microarray data, and
introduced the Gene Expression Commons system as a compre-
hensive discovery platform. The common reference and probeset
meta database provide significant advantages over conventional
relative gene profiling. For each microarray, gene expression can
be measured relative to the common reference that provides
absolute gene expression values for comparison between many
microarray experiments.
The concept of using a common reference to normalize large
amounts of Affymetrix data was first proposed and developed by
Katz et al. [9] in 2006. Katz et al. used 1,614 diverse biological
samples comprised of 251 tissue and pathological categories as the
common reference. In 2007, Day et al., described the Celsius
system in which by a selected ‘quantification pool’ of 50
heterogeneous mixture of samples is held constant for all
quantification events [10]. However, as we shown by computa-
tional simulation in Figure 1b, this size of data pool is not large
enough to establish stable common reference. In our system we
used almost all of the publicly available gene expression data
(.10,000 arrays) to enhance the stability of the common
reference. However, the drawback of this large-scale common
reference strategy is the computational cost of the normalization
process. Each time a new microarray is submitted, the data is re-
normalized against all of the microarrays in large-scale common
reference, which takes several hours on a dedicated server.
Recently, McCall et al. expanded the work of Katz et al. and
develop a new strategy called frozen RMA (fRMA) [11]. fRMA
first computes probe-specific parameters required for normaliza-
tion from large-scale publicly available microarray data, then
normalizes each additional microarray using those pre-computed
values. Therefore, the fRMA method has a significant potential to
improve the processing speed of normalization in Gene Expression
Commons.
Oncomine is a database of cancer microarrays and provides a
platform for differential expression analyses comparing most major
types of cancer with respective normal tissues as well as a variety of
cancer subtypes [12]. In databases like Oncomine, Flymine [13],
Ingenuity, EMAAS [14], MiMiR [15] and many others around
the world, microarray data can be imported, queried and
visualized for a selected gene across all analyses or for multiple
genes in a selected analysis. However, none of these databases
provide an analysis platform for absolute gene expression profiling.
In 2007, Zilliox et at introduced a method to compute thresholds
that distinguish expressed from unexpressed genes, as part of a
system to define tissue-specific ‘gene expression bar codes’, using
1092 manually curated human samples and 236 mouse samples
[16]. They added a web interface in 2011 to obtain a bar code for
a particular sample uploaded by user (http://rafalab.jhsph.edu/
barcode/index.php) [17]. In this method, the authors used the
smallest mode, defined as local maximum of the estimated density
distribution, and standard deviation estimated from expression
(A, right) and Human Hematopoiesis Model (B, right). A list of genes matching each criterion can be obtained with a few clicks on Gene Expression
Commons (https://gexc.stanford.edu/).
doi:10.1371/journal.pone.0040321.g003
Table 4. Microarray gene expression profilings tageting HSC based on relative comparison.
Year Group Platform HSC Compared to # of probes # of genes Ref
2002 Hood House made Rhlow KLS Rhhigh KLS 5000 [21]
2002 Lemischka Affymetrix MU-U74-2 A,C Rhlow KLS Variou type of cells 36000 6000+18000 EST [22]
2003 Akashi Affymetrix MU-U74-2 A,C Thy1.1low Rhlow KLS MPP, CMP, CLP 36000 6000+18000 EST [23]
2003 Weissman Clontech Atlas Mouse cDNA
array
Thy1.1low KLS CMP, CLP, GMP, MEP, ProT,
ProB
1200 [24]
2005 Weissman Stanford Microarray Facility
42 k
mouse cDNA array
Thy1.1low Flk22 KLS Thy1.1low Flk2+ KLS,
Thy1.12
Flk2+ KLS
42000 [25]
2005 Weissman Affymetrix Mouse 430 2.0 CD342 Flk22 KLS
(young)
CD342 Flk22 KLS (old) 45000 34000 [26]
2006 Goodell Affymetrix Mouse U74A SP Sca1+ Gr12 CD8+ T cell 45000 34000 [27]
2007 Goodell Affymetrix Mouse 430 2.0 SP KLS Erythrocyte, Granulocyte,
Native T cell, Activated T
cell,
Activated B cell, Monocyte,
NK cell
45000 34000 [28]
KLS: c-Kit+ Lin2 Sca-1+; MPP: multipotent progenitor; CMP: common myeloid progenitor; CLP: common lymphoid progenitor; GMP: granulocyte/macrophage
progenitor; MEP: megakaryocyte/erythrocyte progenitor; Pro T: progenitor T cell, Pro B: progenitor B cell.
doi:10.1371/journal.pone.0040321.t004
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estimates to the left side of the smallest mode. By contrast, Gene
Expression Commons uses random samples from a large pool of
microarray data as common reference, and sets a threshold to
divide the expression of each gene into ‘‘low’’ and ‘‘high’’ values
(instead of ‘‘present’’ and ‘‘absent’’). This threshold is computed by
sorting the expression values from low to high, then using the
StepMiner algorithm to fit a step function to the data. Low and
high values may be more appropriate for finding signature genes
that differentiate cell types, since genes are often expressed at a low
level in many cell types, but at dramatically higher levels in a small
number of cell types of interest. We would encourage investigators
to experiment with web interfaces for both systems to find out
which method is most appropriate for their purposes.
Since hematopoiesis has been one of the most studied tissue
stem cell based systems, numerous efforts have been invested in
microarray analysis of hematopoietic cells, especially hematopoi-
etic stem cells (Table 4). However, each study used a different
protocol for the purification of HSCs, and used different cell
populations as the counterpart to obtain ‘differentially regulated
genes’. Thus each result is project-specific and is difficult to
generalize.
Recently, more comprehensive approaches to profile gene
expression of hematopoietic systems have been introduced.
BloodExpress collected published microarray data of 37 distinct
mouse hematopoietic populations ex vivo or after culture, as
conducted by 15 different projects/laboratories [18]. Blood-
Express processed each microarray data by the MAS5 method
which does not consider differences in the dynamic ranges of
probesets, and each gene was classified into binary Present or
Absent states. In terms of data processing strategy, BloodExpress’
binarization by MAS5 was a practical first-pass categorization of
gene expression. On the other hand, the data integrated into
BloodExpress were highly heterogeneous, and the classification of
all genes into ‘‘present’’ or ‘‘absent’’ categories is overly simplistic.
In 2008, Heng and Painter proposed an aspiring project named
‘Immgen Project’ to establish a complete ‘road map’ of gene-
expression and regulatory networks in all immune cells [19]. This
project is aiming to generate microarray data of over 200 immune
cell types by a highly standardized protocol. However, they do not
provide absolute gene expression because their arrays are not
compared with arrays from other tissues.
To overcome those limitations, we sorted and profiled 39 mouse
hematopoietic populations using very strict cell surface criteria,
and the most modern sorting strategies. All these data have been
loaded onto the Gene Expression Commons and will be made
available to the public. Moreover, because of the advantage of the
common reference strategy, incorporating additional data of new
populations in future will not detectably change the gene
expression readout of existing populations. Thus, it is our belief
that the Gene Expression Commons will serve as a common
platform for absolute profiling of gene expression in the
hematopoietic system.
The Gene Expression Commons has many other potential uses.
For example, one can enter the name of a gene, and rapidly
determine the quantitative expression of that gene in each cell
type. Alternatively, one can query any cell type within a model to
obtain a list of genes expressed exclusively in that cell type, or
concomitantly with a defined subset of other cell types. This could
be done in mice, where mutant and lineage tracing strains exist to
identify candidate genes that may be important in cellular
differentiation. Another possible use is for pharmacology, where
the expression of drug targets and potential toxicities to
hematopoietic stem and progenitor cells can be predicted.
Here we demonstrate that absolute gene expression profiling
can be achieved by establishing large-common reference data and
meta-analysis. This strategy advances gene expression analysis
beyond conventional profiling with small numbers of samples.
Additionally, this strategy can be applicable to other platforms for
Table 5. Clone and Conjugation of Antibodies Used.
Epitope Clone Fluorescence Vendor
AA4.1 (CD93) AA4.1 APC eBioscience
B220 RA3-6B2 PE-Cy7,
APC-Cy7
eBioscience
B220 RA3-6B2 PacBlue Weissman lab
CD11b M1/70 PE-Cy5,
PE-Cy7
eBioscience
CD11c N418 PE-Cy5.5,
APC-Cy7
eBioscience
CD122 TM-b1 PE eBioscinece
CD19 1D3 PE-Cy5.5 eBioscience
CD21 8D9 PE eBioscience
CD23 B3B4 PECy7 eBioscience
CD25 PC61.5 Pacific orange Weissman lab
CD27 LG.7F9 APC eBioscience
CD3 17A2 Pacific Blue Weissman lab
CD3 17A2 Cy7PE eBioscience
CD3 2C11 Pacific blue Weissman lab
CD34 RAM34 FITC eBioscience
CD4 GK1.5 Alexafluor647,
PB
Weissman lab
CD4 GK1.5 PE-Cy7 eBioscience
CD44 IM7 Alexafluor 680 Weissman lab
CD49b DX5 FITC eBioscience
CD69 H1.2F3 biotin eBioscience
CD8a 53.6.7 Alexafluor488 Weissman lab
CD8a 53.6.7 PE-Cy7 eBiosience
c-Kit 2B8 Alexafluor750 eBioscience
FcgrII/III 2.4g2 PacificOrange Weissman lab
Flk2 A2F10 PE eBioscience
Gamma-delta TCR GL3 PE eBioscience
Gr-1 RB6-8C5 PE-Cy7 eBioscience
IgD 11–26 eFluor 450 eBioscience
IgM II/41 PECy5 eBioscience
IL7Ra A7R34 Biotin, PE-Cy5 eBioscience
Ly6d 49H4.3 FITC, A680,
PacificOragne
Weissman lab
Mac-1 M1/70 Cy5PE eBioscience
NK1.1 PK136 PE-Cy5,
PE-Cy7
eBioscience
Sca-1 E13-161-7 PacificBlue Weissman lab
Slamf1 TC15-12F12.2 PE BioLegend
Thy1.1 OX-7 biotin Weissman lab
Tie-2 TEK4 biotin eBioscience
Ter119 TER 119 PE-Cy7 eBioscience
Vcam-1 429 Alexafluor647 BioLegend
doi:10.1371/journal.pone.0040321.t005
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high-throughput assays including exon arrays, microRNA arrays,
or DNA methylation arrays. The strategy is implemented into a
web-based open platform termed ‘‘Gene Expression Commons’’
(https://gexc.stanford.edu/).
Materials and Methods
Data Collection and Preprocessing
Raw data files for 11,939 Affymetrix 430 2.0 mouse arrays and
25,229 Affymetrix U133 Plus 2.0 human microarrays were
obtained from NIH Gene Expression Omnibus [2]. The data
were normalized and probeset expression levels were generated by
using the standard robust multichip average algorithm [3].
Next, a threshold was assigned to each probeset using the
StepMiner algorithm [4], which was originally designed to fit step
functions to time-course data. For this application, the expression
values for each probeset were ordered from low-to-high, and
StepMiner was used to fit a rising step function to the data that
minimizes the difference between the fitted and measured values.
This approach places the step at the largest jump from low values
to high values (but only if there are sufficiently many expression
values on each side of the jump to provide evidence that the jump
is not due to noise), and sets the threshold at the point where the
step crosses that original data. In the case where the gene
expression levels are evenly distributed from low to high, the
threshold tends to be near the mean expression level.
Animals
All animal procedures were approved by the International
Animal Care and Use Committee and the Stanford Administrative
Panel on Laboratory Animal Care.
Cell Sorting and Antibodies
All cells were sorted and data collected on a BD FACSAria
(Beckton Dickinson, San Jose, CA). FlowJo Software (TreeStar,
OR) was used for flow cytometric data analysis. A complete list of
all antibodies used in the study is shown in Table 5.
Gene Expression Microarray Analysis
Genome-wide gene expression analysis was performed using
Affymetrix GeneChip Mouse Genome 430 2.0 Array (Affymetrix).
For each sample, 1 ug of high-quality total RNA was amplified,
labeled and hybridized onto the microarray at Stanford PAN
facility microarray core according to Affymetrix’s specifications.
Microarray data reported in this manuscript is described in
accordance with MIAME guidelines. The data has been deposited
in GEO public repository (GSE34723).
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